Document Detail


Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.
MedLine Citation:
PMID:  20299739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The renin-angiotensin system (RAS) has been demonstrated to play a critical role in the initiation and progression of atherosclerosis, thereby contributing to development of cardiovascular diseases. Angiotensin II (Ang II), a major substrate in RAS, stimulates atherosclerosis through various deleterious effects such as endothelial dysfunction, cellular proliferation and inflammation. Recently, local RAS in vasculature is reported to play an important role. Many of these atherogenic actions of Ang II are mediated by reactive oxygen species (ROS). Investigation of the role of ROS and inflammation induced by RAS may provide a clue to understanding the pathophysiology of atherosclerotic diseases, and may lead to a new therapeutic strategy.
Authors:
Masataka Sata; Daiju Fukuda
Related Documents :
18666849 - Influence of cd4+/cd25+ regulatory t cells on atherogenesis in patients with end-stage ...
24947359 - Macrophage hif-2α ameliorates adipose tissue inflammation and insulin resistance in obe...
16182129 - Toward immunomodulatory and anti-inflammatory properties of statins.
16141399 - Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: t...
17071609 - Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-...
2669279 - Functions of vascular wall cells related to development of transplantation-associated c...
17206709 - Oral biopsies from patients with orofacial granulomatosis with histology resembling cro...
17707089 - Cystein cathepsin and hsp90 activities determine the balance between apoptotic and necr...
23698769 - Anti-inflammatory effect of ginsenoside rg5 in lipopolysaccharide-stimulated bv2 microg...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The journal of medical investigation : JMI     Volume:  57     ISSN:  1349-6867     ISO Abbreviation:  J. Med. Invest.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-19     Completed Date:  2010-06-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9716841     Medline TA:  J Med Invest     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  12-25     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / pharmacology
Atherosclerosis / etiology*
Bone Marrow / physiology
Humans
Reactive Oxygen Species / metabolism
Receptor, Angiotensin, Type 1 / physiology
Receptor, Angiotensin, Type 2 / physiology
Renin-Angiotensin System / physiology*
Chemical
Reg. No./Substance:
0/Reactive Oxygen Species; 0/Receptor, Angiotensin, Type 1; 0/Receptor, Angiotensin, Type 2; 11128-99-7/Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Radiation therapy: state of the art and the future.
Next Document:  Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in in...